You have 9 free searches left this month | for more free features.

City

Qingdao (2)

Condition

Healthy Subjects (1)

Hormone Sensitive Prostate Cancer (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Jiangsu HengRui Medicine Co., Ltd. (2)

Collaborator

Intervention

shr7280 (2)

placebo oral tablet (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

shr7280

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hormone Sensitive Prostate Cancer Trial in Qingdao (SHR7280)

Recruiting

Hormone Sensitive Prostate Cancer

SHR7280

Qingdao, Shandong, China

The Affiliated Hospital of Qingdao University

Jan 13, 2022

Healthy Subjects Trial in Qingdao (SHR7280, Placebo oral tablet)

Completed

Healthy Subjects

SHR7280
Placebo oral tablet

Qingdao, Shan Dong, China

Affiliated Hospital of Qingdao University

Oct 21, 2021